AQST News

Latest breaking news and updates for AQST stock.

Track all markets on TradingView

Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock

WARREN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improv...

What is the potential impact on short‑term trading volume and volatility around the pricing announcement and subsequent closing? How might the increased cash balance affect AQST’s valuation multiples (e.g., EV/EBITDA, price‑to‑sales) relative to peers? Are there any covenants or restrictions attached to the offering that could limit the company’s operational flexibility?
Capital raise
15 days ago
Read more globenewswire

Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm™ (epinephrine) Sublingual Film

WARREN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improv...

How will this strategic partnership with RT W influence AQST’s strategic positioning and partnership opportunities in the broader drug delivery space? Are there any covenants or performance milestones tied to the RT W funding that could affect future financing? What is the projected revenue and profit contribution of Anaphylm™ once commercialized?
Funding
15 days ago
Read more globenewswire

Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improv...

What is the market's reaction (price movement, volume) to this release, and how does it compare to previous earnings releases? Did management comment on any macroeconomic or regulatory risks that could impact the business? How does the company's performance compare with its direct competitors in the same therapeutic area?
Earnings
17 days ago
Read more globenewswire